AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Broadpeak

Declaration of Voting Results & Voting Rights Announcements Oct 7, 2025

1168_rns_2025-10-07_da658cd6-59ac-42ca-a796-ece203241f1b.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

FR Regulatory | 7 October 2025 08:00

BROADPEAK SA: Disclosure of total number of voting rights and number of shares in the capital as of September 30, 2025

BROADPEAK SA

BROADPEAK SA: Disclosure of total number of voting rights and number of shares in the capital as of September 30, 2025

07-Oct-2025 / 08:00 CET/CEST

Dissemination of a French Regulatory News, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


Press release – For immediate release

October 6, 2025 – 5:45 pm CEST

Disclosure of total number of voting rights and number of shares in the capital as of September 30, 2025

Pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.

Sophia Antipolis, France

Total number of shares 36,279,223
Number of real voting rights* (excluding treasury shares**) 36,195,548
Theoretical number of voting rights* (including treasury shares**) 36,256,023

(*) Class E preference shares are non-voting

(**) pursuant to article 223-11 of the AMF’s General Regulations

About Median Technologies: Pioneering innovative software as a medical device and imaging services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median’s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis®, an AI/ML tech-based suite of software as a medical device (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit www.mediantechnologies.com .

Contacts

Median Technologies

Emmanuelle Leygues

VP, Corporate Marketing & Financial Communications

+33 6 10 93 58 88

[email protected]
Press – Ulysse Communication

Bruno Arabian

+33 6 87 88 47 26

[email protected]

Nicolas Entz

+33 6 33 67 31 54

[email protected]
Investors – ACTIFIN

Ghislaine Gasparetto

+33 6 85 36 76 81

[email protected]

Regulatory filing PDF file

File: 20251007 – BPK _ CP _ DDV au 01-10-2025

- - -
Language: English
Company: BROADPEAK SA
15 rue Claude Chappe
35510 CESSON SEVIGNE
France
Phone: 02 22 74 03 50
Internet: https://broadpeak.tv/
ISIN: FR001400AJZ7
Euronext Ticker: ALBPK
AMF Category: Total number of voting rights and share capital / Information on the total number of voting rights and the number of shares making up the share capital
EQS News ID: 2208772
End of Announcement EQS News Service

2208772  07-Oct-2025 CET/CEST

Talk to a Data Expert

Have a question? We'll get back to you promptly.